Properties in polysulfur aromatic alkaloids found in Pacific sea squirts, sac-like marine invertebrate filter feeders, have the potential to kill cancer cells, including pleural mesothelioma, according to Surviving Mesothelioma. (more…)
Posts Tagged ‘pleural mesothelioma’
Despite each of the 910 Australian patients with pleural mesothelioma who participated receiving some level of compensation for their diseases, the study found those with lower statuses on the Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD) were less likely to receive adequate treatment, according to Surviving Mesothelioma. (more…)
Mesothelioma Research News reports the study, published in Pathology & Oncology Research at the beginning of the year, has linked the WT1 protein to the survival of malignant pleural mesothelioma (MPM). (more…)
The findings help explain why some of the doctors’ patients with malignant pleural mesothelioma (MPM), which affects the lining of the lungs and is associated with the inhalation of asbestos, also developed gallbladder disorders, including gallstones or cholecystitis, an inflammation of its tissue that can result in fever, nausea, vomiting and jaundice.
Surviving Mesothelioma explains that the study’s results show asbestos fibers, which remain in the body because the particles cannot be removed due to their odd size and shape, do not necessarily stop traveling once they first reach epithelial tissue; the study cites connective tissue as the travel mechanism for asbestos that reaches the gallbladder. (more…)
Research supports multimodal therapy, using various treatment tactics, when treating mesothelioma. The deadly cancer, associated with exposure to asbestos fibers, can affect the lining of the lungs, heart or abdomen, and due to a long latency period, mesothelioma is often hard to detect until it has progressed to its later stages, making treatment difficult. Multimodal therapy often includes combinations of surgery, radiation and chemotherapy, but it can also include a possibly unexpected tool: light. (more…)
It is no secret that mesothelioma can be difficult to diagnose. By the time patients have symptoms, the disease may already be in its later stages. A new study by researchers at Queen Elizabeth University Hospital in Glasgow has added another layer to that difficulty.
Based on their conclusions, contrast-enhanced computed tomography (CT) scans may not be sensitive enough to confirm or discredit a pleural mesothelioma diagnosis, according to Surviving Mesothelioma. (more…)
Subzero temperatures aren’t what many would call beneficial to human health, especially during chilly winter months, but a recent study has found extreme cold can be beneficial in treating mesothelioma tumors, according to Surviving Mesothelioma.
Specifically, the University of California, Los Angeles study, published in the Journal of Vascular and Interventional Radiology, finds cryoablation or cryosurgery has beneficial results for patients with pleural mesothelioma cancer, a type of mesothelioma normally caused by the inhalation of asbestos particles and affecting the lining of the lungs. (more…)
The search to reduce the number of deaths caused by cancer is a main focus of the medical research community. Each discovery is a potential life saved, and Dr. Michele Carbone, who was featured in last month’s International Association for the Study of Lung Cancer’s Lung Cancer News, is one of a team of doctors who uncovered a huge clue in the fight against mesothelioma.
Mesothelioma is a cancer that can affect the lining of the heart, lungs or stomach and is closely associated with the inhalation or ingestion of asbestos, a group of silicate minerals known to cause cancer in humans.
In Lung Cancer News, Dr. Carbone discussed his and his team’s 2011 discovery of the link between a genetic mutation in the BAP1 gene and the development of pleural mesothelioma, which affects the lining of the lungs. (more…)
Mesothelioma is a rare cancer associated with asbestos exposure that only affects approximately 3,000 people per year, making it difficult to diagnose as symptoms often overlap with other medical ailments. Having no definitive way to test for the most common form, pleural mesothelioma, which affects the lining of the lungs, makes diagnosing a patient all the more difficult.
A cancer vaccine being clinically tested in mesothelioma patients continues to gain traction.
Earlier this month, Targovax, the immune-oncology company developing the vaccine, acquired a European patent for its new ONCOS-102 product after receiving a patent for the cancer vaccine in May from the United States.
The vaccine, now in the beginning trial stages, generates viruses, called oncolytic viruses, that specifically target and infect cancer cells and function as immune activators. A previous Phase I trial reported ONCOS-102 treatment induced tumor-specific immune activation both at a systemic and lesional level in tumors of late stage cancer patients. (more…)